Pharmaceutical Benefit Manager Abuse Prevention Act of 2006

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

R BoozmanSponsor

No cosponsors.

Pharmaceutical Benefit Manager Abuse Prevention Act of 2006 - Prohibits a pharmaceutical benefit manager from: (1) referring a patient to a pharmacy or other dispenser of pharmaceuticals that is owned or affiliated with the manager; or (2) changing the drug authorization for a patient without the patient's express consent and without informing the patient…

What it does: CRS summary · Introduced in House · Jul 28, 2006

Requires each pharmaceutical benefit manger to publicly disclose any kickbacks or other financial incentives or any relationship with any pharmaceutical manager.

Provides for civil penalties for violations.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Pharmaceutical Benefit Manager Abuse Prevention Act of 2006

Latest action (Aug 1, 2006): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Jul 28, 2006

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.